Compound 436
Identifiers
- Canonical SMILES:
Oc1c(Cl)cc(Cl)cc1S(=O)(=O)NCc1cccc(CN(Cc2ccccc2SC(F)(F)F)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)c1
- InChi:
InChI=1S/C28H21Cl4F3N2O6S3/c29-19-9-21(31)26(38)24(11-19)45(40,41)36-13-16-4-3-5-17(8-16)14-37(15-18-6-1-2-7-23(18)44-28(33,34)35)46(42,43)25-12-20(30)10-22(32)27(25)39/h1-12,36,38-39H,13-15H2
- InChiKey:
USZBTZHBUOCCQI-UHFFFAOYSA-N
External links
87075791 |
External search
Bibliography (1)
Publication | Name |
---|---|
Kyoung S. Kim, Robert M. Borzilleri, Zhen-Wei Cai, Kap-Sun Yeung, Bristol-Myers Squibb Company. . Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors None. | 64 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 7.02 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 773.93 g/mol | |||
HBA | 8 | |||
HBD | 3 | |||
HBA + HBD | 11 | |||
AlogP | 8.81 | |||
TPSA | 124.01 | |||
RB | 10 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009152082 | 64 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 7.02 | |
WO2009152082 | 64 | MCL1 Q07820 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.77 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5812 | N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide | DB07115 | |
0.4496 | Saccharin | DB12418 | |
0.4410 | Evatanepag | DB12022 | |
0.4398 | 2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE | DB08000 | |
0.4311 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.4308 | Sulfabenzamide | DB09355 | |
0.4130 | UK-390957 | DB11719 | |
0.4118 | AL5927 | DB03526 | |
0.4111 | CGS-27023 | DB07556 | |
0.3944 | Taprenepag | DB12623 | |
0.3925 | {4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID | DB07999 | |
0.3906 | Repinotan | DB06506 | |
0.3889 | 3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE | DB08487 | |
0.3812 | 2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid | DB03207 | |
0.3810 | (2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE | DB07568 |